These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 38950713)
41. Plasma miR-193b-3p Is Elevated in Type 2 Diabetes and Could Impair Glucose Metabolism. Hu H; Zhao M; Li Z; Nie H; He J; Chen Z; Yuan J; Guo H; Zhang X; Yang H; Wu T; He M Front Endocrinol (Lausanne); 2022; 13():814347. PubMed ID: 35712251 [TBL] [Abstract][Full Text] [Related]
42. miR-193b-3p Promotes Proliferation of Goat Skeletal Muscle Satellite Cells through Activating IGF2BP1. Li L; Zhang X; Yang H; Xu X; Chen Y; Dai D; Zhan S; Guo J; Zhong T; Wang L; Cao J; Zhang H Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555418 [TBL] [Abstract][Full Text] [Related]
43. PGC-1 alpha interacts with microRNA-217 to functionally regulate breast cancer cell proliferation. Zhang S; Liu X; Liu J; Guo H; Xu H; Zhang G Biomed Pharmacother; 2017 Jan; 85():541-548. PubMed ID: 27916422 [TBL] [Abstract][Full Text] [Related]
44. High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model. Kong Y; Liang X; Liu L; Zhang D; Wan C; Gan Z; Yuan L PLoS One; 2015; 10(9):e0137432. PubMed ID: 26361355 [TBL] [Abstract][Full Text] [Related]
45. MicroRNA-193b-3p regulates chondrogenesis and chondrocyte metabolism by targeting HDAC3. Meng F; Li Z; Zhang Z; Yang Z; Kang Y; Zhao X; Long D; Hu S; Gu M; He S; Wu P; Chang Z; He A; Liao W Theranostics; 2018; 8(10):2862-2883. PubMed ID: 29774080 [TBL] [Abstract][Full Text] [Related]
46. miR-494-3p modulates the progression of in vitro and in vivo Parkinson's disease models by targeting SIRT3. Geng L; Zhang T; Liu W; Chen Y Neurosci Lett; 2018 May; 675():23-30. PubMed ID: 29567426 [TBL] [Abstract][Full Text] [Related]
47. LncRNA miR-17-92a-1 cluster host gene (MIR17HG) promotes neuronal damage and microglial activation by targeting the microRNA-153-3p/alpha-synuclein axis in Parkinson's disease. Zhang J; Yang Y; Zhou C; Zhu R; Xiao X; Zhou B; Wan D Bioengineered; 2022 Feb; 13(2):4493-4516. PubMed ID: 35137671 [TBL] [Abstract][Full Text] [Related]
48. LncRNA DLX6-AS1 promotes microglial inflammatory response in Parkinson's disease by regulating the miR-223-3p/NRP1 axis. Liu L; Zhou T; Li T; Liang Z; Luo X Behav Brain Res; 2022 Aug; 431():113923. PubMed ID: 35550840 [TBL] [Abstract][Full Text] [Related]
49. MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells. Lin SR; Yeh HC; Wang WJ; Ke HL; Lin HH; Hsu WC; Chao SY; Hour TC; Wu WJ; Pu YS; Huang AM J Cell Biochem; 2017 Jun; 118(6):1563-1573. PubMed ID: 27918099 [TBL] [Abstract][Full Text] [Related]
51. Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axis. Wang H; Chen W; Yang P; Zhou J; Wang K; Tao Q Cancer Biol Ther; 2019; 20(4):461-473. PubMed ID: 30404587 [TBL] [Abstract][Full Text] [Related]
52. Peroxisome proliferator-activated receptor-γ coactivator 1α-mediated pathway as a possible therapeutic target in endometriosis. Kataoka H; Mori T; Okimura H; Matsushima H; Ito F; Koshiba A; Tanaka Y; Akiyama K; Maeda E; Sugahara T; Tarumi Y; Kusuki I; Khan KN; Kitawaki J Hum Reprod; 2019 Jun; 34(6):1019-1029. PubMed ID: 31119261 [TBL] [Abstract][Full Text] [Related]
53. Expression of the gene coading for PGC-1α in peripheral blood leukocytes and related gene variants in patients with Parkinson's disease. Yang XD; Qian YW; Xu SQ; Wan DY; Sun FH; Chen SD; Xiao Q Parkinsonism Relat Disord; 2018 Jun; 51():30-35. PubMed ID: 29496354 [TBL] [Abstract][Full Text] [Related]
54. SOS1-IT1 silencing alleviates MPP Fan J; Wu D; Guo Y; Yang Z J Clin Neurosci; 2022 May; 99():137-146. PubMed ID: 35279586 [TBL] [Abstract][Full Text] [Related]
56. Regulation of PGC-1α mediated by acetylation and phosphorylation in MPP+ induced cell model of Parkinson's disease. Fan F; Li S; Wen Z; Ye Q; Chen X; Ye Q Aging (Albany NY); 2020 May; 12(10):9461-9474. PubMed ID: 32452827 [TBL] [Abstract][Full Text] [Related]
57. MiR-212 Attenuates MPP⁺-Induced Neuronal Damage by Targeting KLF4 in SH-SY5Y Cells. Song Y; Liu Y; Chen X Yonsei Med J; 2018 May; 59(3):416-424. PubMed ID: 29611404 [TBL] [Abstract][Full Text] [Related]
58. A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease. Fazeli S; Motovali-Bashi M; Peymani M; Hashemi MS; Etemadifar M; Nasr-Esfahani MH; Ghaedi K PLoS One; 2020; 15(11):e0240855. PubMed ID: 33171483 [TBL] [Abstract][Full Text] [Related]
59. PGC-1α Promoter Methylation in Parkinson's Disease. Su X; Chu Y; Kordower JH; Li B; Cao H; Huang L; Nishida M; Song L; Wang D; Federoff HJ PLoS One; 2015; 10(8):e0134087. PubMed ID: 26317511 [TBL] [Abstract][Full Text] [Related]
60. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease. Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]